Thierry Dervieux PharmD, PhD is our Chief Scientific Officer. Prior to joining Prometheus, Thierry was Chief Scientific Officer at Exagen Diagnostics where he spent a decade building the Avise® portfolio of testing solutions to diagnose, prognose and monitor autoimmune rheumatic diseases, the success of which led to an initial public offering for the company. Prior to Exagen, Thierry led diagnostic and precision dosing development efforts at Cypress Biosciences, Proprius Pharmaceuticals (acquired by Cypress) and Prometheus Laboratories. Thierry is certified by the American Board of Clinical Chemistry in Clinical Chemistry and Molecular Diagnostics, and holds PharmD and PhD degrees from Claude Bernard University in Lyon, France. He also trained at St. Jude Children’s Research Hospital in Memphis, Tennessee. Thierry is the inventor or co-inventor on several patents and patent applications, has authored or co-authored over 60 publications.